About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5906 record(s)
Req # A-2024-000028
Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20. Report numbers: 000709470, 000720165.Organization: Health Canada
April 2024
Req # A-2024-000032
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.Organization: Health Canada
April 2024
Req # A-2024-000068
Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.Organization: Health Canada
April 2024
Req # A-2024-013
Pursuant to the Access to Information Act, R.S.C. 1985, c. A-1, I hereby request access to the following records: 1. A copy of the agreement(s) involving the Canada Infrastructure Bank (CIB), Macquarie Asset Management, Porter Aviation Holdings Inc., the Montreal Metropolitan Airport (YHU), and/or any related companies in relation to the investment project for the development of a new domestic airport terminal at the Montreal Metropolitan Airport (YHU). 2. A copy of any reports, plans, prospectuses, or similar documents related to the above-referenced investment project.Organization: Canada Infrastructure Bank
March 2024
Req # A-2023-00040
Provide from January 1, 2023, to present, any available projected costs for running the next election. Additionally, please provide any documents pertaining to any significant changes in election procedures for dealing with election interference or reaching out to people with no fixed address (exclude drafts, except for the latest one).Organization: Elections Canada
March 2024
Req # A-2023-00068
Policy interpretations related to large virtual currency transaction reportingOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00072
Various 2022 and 2023 statistics on money services businesses; relating to the amount of businesses registered, number of employees, policy interpretations requested, volume of transactions, and deficiencies found in compliance examinationsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00089
Questions, answers and interpretations concerning politically exposed personsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024